Coexistence of familial antiphospholipid syndrome and factor V Leiden: Impact on thrombotic diathesis

British Journal of Haematology

Volumn 94, Issue 1, 1996, Pages 166-167

  Brenner, B ^a   Vulfsons, S L ^a   Lanir, N ^a   Nahir, M ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Antiphospholipid syndrome; Protein C resistance; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 5 LEIDEN; CARBAMAZEPINE; CYCLOPHOSPHAMIDE; DILTIAZEM; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; PREDNISONE; PROTEIN C; WARFARIN;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; THROMBOSIS;

EID: 0030015654     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1757.x     Document Type: Article

References (12)

1. Asherson, R.A., Khamashta, M.A., Ordi-Ros, J., Derksen. R.H., Machin, S.J., Barquinero, J., Outt, H.H., Harris, E.N., Vilardell-Torres, M. & Hughes, G. R. (1989) The 'primary' antiphospholipid syndrome: major clinical and serological features. Medicine, 68, 366-374.
2. Bertina, R.M., Koeleman, B.P.C., Koster, T., Rosendaal, F.R., Dirven, R.J., de Ronde, H., van der Velden, P.A. & Reitsma, P.H. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature, 369, 64-67.
3. Brenner, B., Zivelin, A., Lanir, N., Greengard, J.S., Griffin, J.H. & Seligsohn, U. (1996) Hereditary thrombophilia as a multigenic disease: increased thrombotic risk due to combined hereditary heterozygous protein C deficiency and activated protein C. Blood, in press.
4. Dahlback, B., Carlsson, M. & Svensson, P.J. (1993) Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proceedings of the National Academy of Sciences of the United States of America. 90, 1004-1008.
5. Ford, P.M., Brunet, D., Lillicrap, D.P. & Ford, S.E. (1990) Premature stroke in a family with lupus anticoagulant and antiphospholipid antibodies. Stroke, 21, 66-71.
6. Griffin. J.H., Heeb, M.J., Kozima, Y., Fernandez. J.A., Kozima, K., Hackeng, T.M. & Greengard, J.S. (1995) Activated protein C resistance: molecular mechanisms. Thrombosis and Haemostasis, 74. 444-448.
7. Kamashta, M.A., Cuadrado, M.J., Mujie, F., Taub, N.A., Hunt, B.J. & Hughes, G.R.V. (1995) The management of thrombosis in the antiphospholipid antibody syndrome. New England Journal of Medicine, 332, 993-997.
8. Koelman, B.P.C., Reitsma, P.H., Allaart, C.F. & Bertin, R.M. (1994) Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. Blood, 84. 1031-1035.
9. Mandel, H., Brenner, B., Berant, M., Rosenberg, N., Lanir, N., Jacobs, C., Fowler, B. & Seligsohn, U. (1996) Coexistence of hyperhomocysteinemia and factor V Leiden mutation: impact on expression of thrombosis. New England Journal of Medicine, 334, 763-768.
10. Matthey, F., Walshe, K., Mackie, I.J. & Machin, S.J. (1989) Familial occurrence of the antiphospholipid syndrome. Journal of Clinical Pathology. 42, 495-497.
11. Costing. J.D., Derksen, R.H.W.M., Bobbink, I.W.G., Hackeng, T.M., Bouma, B.M. & de Groot, P.G. (1993) Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism? Blood, 81, 2618-2625.
12. Pettee, A.D., Wasserman, B.A., Adams, N.L., McMullen. VV., Smith, H.R., Woods, S.L. & Ratnoff, O.D. (1994) Familial Sneddon's syndrome: clinical, hematologic and radiographic findings in two brothers. Neurology, 44, 399-405.